摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,6-二溴-2-甲氧基萘 | 66996-59-6

中文名称
1,6-二溴-2-甲氧基萘
中文别名
——
英文名称
1,6-dibromo-2-methoxynaphthalene
英文别名
——
1,6-二溴-2-甲氧基萘化学式
CAS
66996-59-6
化学式
C11H8Br2O
mdl
——
分子量
315.992
InChiKey
HFEOLDKRKNUVAD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    102 °C
  • 沸点:
    371.9±22.0 °C(Predicted)
  • 密度:
    1.756±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2909309090
  • 包装等级:
    III
  • 危险类别:
    9
  • 危险性防范说明:
    P261,P273,P280,P305+P351+P338
  • 危险品运输编号:
    3077
  • 危险性描述:
    H315,H318,H335,H411
  • 储存条件:
    | 存储温度 | 存储条件 | | --- | --- | | 2-8°C | 干燥 |

SDS

SDS:5c491c1cf0e1a2f4421b0986d9dc2760
查看

制备方法与用途

用途:萘普生和萘丁美酮的中间体。

生产方法:通过将β-萘酚进行醚化、溴化反应制备而成。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • A Doubly Biomimetic Synthetic Transformation: Catalytic Decarbonylation and Halogenation at Room Temperature by Vanadium Pentoxide
    作者:Sujoy Rana、Bhawana Pandey、Aniruddha Dey、Rameezul Haque、Gopalan Rajaraman、Debabrata Maiti
    DOI:10.1002/cctc.201600843
    日期:2016.11.8
    intermediate vanadium‐oxo‐peroxo species, which was characterized by using 51 V NMR, UV/Vis, and resonance Raman spectroscopy. Further detection of formic acid from the reaction mixture confirmed the biomimetic aspects of decarbonylative halogenation. A detailed experimental and DFT study indicated a concerted mechanism for this decarbonylative halogenation performed under simple and mild reaction conditions
    金属-过氧-过氧物种对CH键的卤化和金属-过氧-物种对醛的脱羰是在生物系统中常规进行的。但是,金属介导的脱羰卤化反应本质上是未知的。在这项工作中,我们表明,广泛使用的V 2 O 5和VO(acac)2(acac =乙酰丙酮)可以通过生成中间钒-氧-过氧物质来催化脱羰卤化反应,其特征是使用51 1 H NMR,UV / Vis和共振拉曼光谱。从反应混合物中进一步检测甲酸证实了脱羰基卤化的仿生方面。详尽的实验和DFT研究表明,在简单温和的反应条件下进行该脱羰基卤化反应的协调机制。
  • Substituted 6-Phenyl-2-naphthols. Potent and Selective Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1): Design, Synthesis, Biological Evaluation, and Pharmacokinetics
    作者:Sandrine Marchais-Oberwinkler、Patricia Kruchten、Martin Frotscher、Erika Ziegler、Alexander Neugebauer、Umadevi Bhoga、Emmanuel Bey、Ursula Müller-Vieira、Josef Messinger、Hubert Thole、Rolf W. Hartmann
    DOI:10.1021/jm800367k
    日期:2008.8.1
    concentration is mainly regulated by 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1), which catalyzes the reduction of the weak estrogen estrone (E1) to the highly potent E2. This enzyme is thus an important target for the treatment of hormone-dependent diseases. Thirty-seven novel substituted 6-phenyl-2-naphthols were synthesized and evaluated for 17beta-HSD1 inhibition, selectivity toward 17beta-HSD2
    17β-雌二醇(E2)与雌激素依赖性疾病的发生和发展有关。它的浓度主要受17beta-羟类固醇脱氢酶1型(17beta-HSD1)调节,该酶催化将弱雌激素雌酮(E1)还原为强效E2。因此,该酶是治疗激素依赖性疾病的重要靶标。合成了37种新型取代的6-苯基-2-萘酚,并评估了其对17beta-HSD1的抑制作用,对17beta-HSD2和雌激素受体(ER)α和β的选择性以及药代动力学特性。SAR研究表明,这些化合物最有可能根据结合模式B与活性位点结合,即与类固醇A环类似的6-苯基部分。虽然苯环上的取代会降低活性,
  • Human Papillomavirus and Risk of Laryngeal Cancer
    作者:Elaine M. Smith、Kurt F. Summersgill、Timothy McCulloch、Jeffrey Allen、Lubomir P. Turek、Henry T. Hoffman、Thomas H. Haugen
    DOI:10.1177/000348940010901114
    日期:2000.11

    We determined the relationship between human papillomavirus (HPV) infection and the HPV types detected in 44 patients with squamous cell carcinoma, 10 laryngeal leukoplakia patients, and 12 patients evaluated for benign laryngeal conditions (controls). The sources of HPV DNA were from brushings from the upper respiratory tract and lesion (benign or malignant), oral rinses, and biopsies of patient lesions. Polymerase chain reaction (PCR) and DNA sequencing were used to identify and type HPV. We detected HPV in 25.0% (11/44) of patients with laryngeal cancer, in 30.0% (3/10) of patients with laryngeal leukoplakia, and in 16.7% (2/12) of noncancer controls. Patients with cancer were not more likely to be identified with oncogenic HPV types (18.2%) than either the leukoplakia group (20%) or the control group (16.7%). An increased risk of disease was associated with current tobacco use and former alcohol drinking in cancer patients versus controls and in leukoplakia patients versus controls (all p < .05). After we controlled for tobacco and alcohol effects on the risk of disease, exposure to oncogenic HPV types was associated with an increased risk of laryngeal cancer (odds ratio = 3.0) and of laryngeal leukoplakia (odds ratio = 6.0) compared to controls, although the results were not statistically significant. This study suggests that although HPV infection and HPV oncogenic types are not found at a higher frequency in laryngeal cancer or laryngeal leukoplakia as compared to controls, infection is associated with an increased risk of disease after controlling for the effects of alcohol and tobacco use.

    我们确定了人乳头瘤病毒(HPV)感染与44名鳞状细胞癌患者、10名喉白斑患者和12名良性喉部疾病患者(对照组)检测到的HPV类型之间的关系。HPV DNA的来源包括来自上呼吸道和病变(良性或恶性)的刷拭、口腔漱洗和患者病变的活检。使用聚合酶链反应(PCR)和DNA测序来鉴定和分类HPV。我们在44名喉癌患者中检测到25.0%(11/44)的HPV,在10名喉白斑患者中检测到30.0%(3/10)的HPV,在非癌症对照组中检测到16.7%(2/12)的HPV。癌症患者更有可能被识别为致癌性HPV类型(18.2%)而不是白斑组(20%)或对照组(16.7%)。与对照组相比,癌症患者与白斑患者与疾病风险增加相关联,与目前吸烟和过去饮酒有关(所有p < .05)。在控制烟草和酒精对疾病风险的影响后,暴露于致癌性HPV类型与增加患喉癌(比值比=3.0)和患喉白斑(比值比=6.0)的风险相关联,尽管结果在统计学上不显著。该研究表明,尽管与对照组相比,在喉癌或喉白斑中HPV感染和HPV致癌类型的频率并不更高,但在控制酒精和烟草使用的影响后,感染与疾病风险增加相关联。
  • Heteroaryl-Substituted Naphthalenes and Structurally Modified Derivatives:  Selective Inhibitors of CYP11B2 for the Treatment of Congestive Heart Failure and Myocardial Fibrosis
    作者:Marieke Voets、Iris Antes、Christiane Scherer、Ursula Müller-Vieira、Klaus Biemel、Catherine Barassin、Sandrine Marchais-Oberwinkler、Rolf W. Hartmann
    DOI:10.1021/jm0503704
    日期:2005.10.1
    a novel strategy for the treatment of congestive heart failure and myocardial fibrosis. In this study the synthesis and biological evaluation of heteroaryl-substituted naphthalenes and quinolines (1-31) is described. Key step for the preparation of the compounds was a Suzuki cross-coupling. Activity of the compounds was determined in vitro using human CYP11B2 and selectivity was evaluated toward the
    最近,我们提出抑制醛固酮合酶(CYP11B2)作为一种治疗充血性心力衰竭和心肌纤维化的新策略。在这项研究中,描述了杂芳基取代的萘和喹啉(1-31)的合成和生物学评估。制备化合物的关键步骤是铃木交叉偶联。使用人CYP11B2在体外确定化合物的活性,并评估对人类固醇生成酶CYP11B1,CYP19和CYP17的选择性。已鉴定出大量的CYP11B2高活性和选择性抑制剂。活性最高的抑制剂是6-氰基化合物8(IC50 = 3 nM),显示出竞争性的抑制类型(K(i)值= 1.9 nM)。发现6-乙氧基衍生物5是最具选择性的CYP11B2抑制剂(IC50 = 12 nM; K(i)值= 8 nM; CYP11B1 IC50 = 5419 nM;选择性因子= 451),显示没有对人CYP3A4(50 nM)和CYP2D6(20 nM)的抑制作用。使用我们的同源性建模的CYP11B2结构与所选化合物进行了
  • Ligand-Free Ni-Catalyzed Reductive Cleavage of Inert Carbon–Sulfur Bonds
    作者:Nekane Barbero、Ruben Martin
    DOI:10.1021/ol2033306
    日期:2012.2.3
    A catalytic reductive cleavage of C(sp2)– and C(sp3)–SMe bonds under ligandless conditions is presented. The method is characterized by its wide scope and high chemoselectivity profile including challenging substrate combinations, allowing the design of orthogonal and site-selectivity approaches.
    提出了在无配体条件下C(sp 2)–和C(sp 3)–SMe键的催化还原裂解。该方法的特点是适用范围广,化学选择性高,包括具有挑战性的底物组合,可设计正交和位点选择性方法。
查看更多